(0)
DUBAI, U.A.E., May 25, 2021 /PRNewswire/ -- ESOMAR-certified consulting firm Future Market Insights recently published a report on the global ophthalmic eyes drop market for the forecast period 2021-2031. As per the study, the market is expected to expand at over 5% CAGR through 2021 & beyond. Surging cases of post-operative eye infections and ocular surgical cases such as glaucoma, cataract and many more is furthering the sales of dilation eye drops.
Ocular surgical conditions such as diabetic retinopathy, age-related macular degeneration and glaucoma has increased the demand for post-operative ocular anti-infective therapies. Also, rising cases of bacterial and viral conjunctivitis and emergence of various pathogens have increased the risk of eye infection, thereby fostering the sales of ophthalmic eye drops.